1. Decreased Antibody Response to Influenza Vaccination in Kidney Transplant Recipients: A Prospective Cohort Study 
Kelly A. Birdwell, MD, MSCI, Mine R. Ikizler, MS, Edith C. Sannella, MT, Li Wang, MS, Daniel W. Byrne, MS, T. Alp Ikizler, MD, Peter F. Wright, MD 
American Journal of Kidney Diseases 
Volume 54, Issue 1, Pages (July 2009)
DOI: /j.ajkd
Copyright © 2009 National Kidney Foundation, Inc. Terms and Conditions

2. Figure 1 Study enrollment and follow up.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2009 National Kidney Foundation, Inc. Terms and Conditions

3. Figure 2
Serological response to the inactivated influenza vaccine expressed as geometric mean titers. For the control group: A/H1N1 prevaccination (pre), 33.6, postvaccination (post), 108.9; A/H3N2 pre, 36.7, post, 180.4; B pre, 36.1, post, For the transplant recipient group, A/H1N1 pre, 34.2, post, 53.2; A/H3N2 pre, 23.8, post, 55.7; B pre, 40, post, 80.2.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2009 National Kidney Foundation, Inc. Terms and Conditions

4. Figure 3
Odds ratios (95% confidence intervals) for the primary outcome of seroresponse (4-fold increase in antibody titer).
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2009 National Kidney Foundation, Inc. Terms and Conditions

5. Figure 4
Odds ratios (95% confidence intervals) for the primary outcome of seroprotection (antibody titer ≥ 1:32).
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2009 National Kidney Foundation, Inc. Terms and Conditions